🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
There is currently no standardized treatment for patients who have undergon...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2023-08-16
Trial ID
NCT06063018
Treatments Being Tested
This is a prospective, open, single-center clinical study of anti-HER2-ADC ...
Status
Unknown
Location
Ethics Committee of Shanghai Renji Hospital
Start Date
2023-08-05
Trial ID
NCT05957757
Treatments Being Tested
The goal of this clinical trial is to learn if the combination of disitamab...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-04
Trial ID
NCT07507526
Treatments Being Tested
This is a prospective, multicentre, single-arm phase II study evaluating a ...
Status
Not Yet Recruiting
Location
Ethics Committee of Shanghai Renji Hospital
Start Date
2026-05-31
Trial ID
NCT07584733
Treatments Being Tested
This is a prospective, single arm, multicenter phase II study aimed at eval...
Status
Active Not Recruiting
Location
Central Hospital Affiliated to Shandong First Medical University
Start Date
2023-02-10
Trial ID
NCT05586061
Treatments Being Tested
As an established therapeutic target, HER2 is widely used in a variety of t...
Status
Unknown
Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Start Date
2023-07-18
Trial ID
NCT05578287
Treatments Being Tested
Among patients with colonrectal cancer, 5% were HER-2 positive, but the imm...
Status
Unknown
Location
Changzhou NO.2 People's Hospital
Start Date
2022-08-01
Trial ID
NCT05493683
Treatments Being Tested
Neoadjuvant chemotherapy treatment can be used for specific UTUC patients, ...
Status
Recruiting
Location
The Second Hospital of Tianjin Medical University
Start Date
2022-12-30
Trial ID
NCT05837806
Treatments Being Tested
The efficacy and safety of combination with Disitamab Vedotin and with Tisl...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2024-09-01
Trial ID
NCT06560528
Treatments Being Tested
Disitamab Vedotin combined therapy locally advanced or metastatic NSCLC Pat...
Status
Unknown
Location
SunYat-senU
Start Date
2023-05
Trial ID
NCT05847764
Treatments Being Tested